Jpmorgan Chase & CO HALOZYME THERAPEUTICS INC Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025
Number of Shares
6,335,000
Previous 5,395,000 17.42%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
N/A
940,000 Added 17.42%
6,335,000 $0
Q4 2024

Feb 12, 2025
SELL
N/A
-2,428,000 Reduced 31.04%
5,395,000 $0
Q3 2024

Dec 26, 2024
BUY
N/A
4,422,000 Added 130.02%
7,823,000 $0
Q3 2024

Nov 08, 2024
BUY
N/A
4,422,000 Added 130.02%
7,823,000 $0
Q2 2024

Dec 26, 2024
SELL
N/A
-4,422,000 Reduced 56.53%
3,401,000 $0
Q2 2024

Aug 12, 2024
BUY
N/A
2,581,000 Added 314.76%
3,401,000 $0
Q1 2024

Dec 26, 2024
SELL
N/A
-7,003,000 Reduced 89.52%
820,000 $0
Q1 2024

May 10, 2024
SELL
N/A
-1,137,000 Reduced 58.1%
820,000 $0
Q4 2023

Dec 26, 2024
SELL
N/A
-5,866,000 Reduced 74.98%
1,957,000 $0
Q4 2023

Feb 12, 2024
BUY
N/A
573,000 Added 41.4%
1,957,000 $0
Q3 2023

Nov 14, 2023
BUY
N/A
1,384,000 New
1,384,000 $0
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email